KALA BIO, Inc.
KALA
Rank in Stocks
#31260
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Share Price
$0.1773
Last synced: 2026-11-09
Market Cap
$3.43M
Change (1 day)
13.73%
Change (1 year)
-99.52%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade KALA BIO, Inc. (KALA)
Category
Healthcare
Operating Margin for KALA BIO, Inc. (KALA)
Operating Margin as of November 2026 TTM: 0.00%
According to KALA BIO, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for KALA BIO, Inc. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | -2,090.34% | 114.70% |
| 2021 | -973.60% | -35.63% |
| 2020 | -1,512.59% | 4.14% |
| 2019 | -1,452.49% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | -35,435.56% | 803.77% |
| 2014 | -3,920.88% | -82.39% |
| 2013 | -22,264.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about KALA BIO, Inc.'s operating margin
What was KALA BIO, Inc.'s operating margin in 2025?
In 2025, KALA BIO, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has KALA BIO, Inc.'s operating margin changed since 2020?
From 2020 to 2025, KALA BIO, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2022 (-2,090.34%).
How does KALA BIO, Inc.'s operating margin compare with similar companies?
KALA BIO, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.